AbbVie (ABBV) Short-term Investments (2012 - 2025)

AbbVie (ABBV) has 14 years of Short-term Investments data on file, last reported at $28.0 million in Q4 2025.

• Short-term Investments for Q4 2025 came in at $28.0 million, down 9.68% year-over-year; the trailing twelve-month figure through Dec 2025 was $28.0 million (down 9.68% YoY), and the FY2025 annual result was $28.0 million, down 9.68% from the prior year.
• Short-term Investments slipped to $28.0 million in Q4 2025 per ABBV's latest filing, from $42.0 million in the prior quarter.
• Over five years, Short-term Investments peaked at $1.5 billion in Q1 2022 and troughed at $1.0 million in Q1 2025.
• A 5-year average of $178.8 million and a median of $28.0 million in 2022 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2022 and 2023: Short-term Investments soared 6600.0% in 2022, then plunged 99.51% in 2023.
• A 5-year view of Short-term Investments shows it stood at $84.0 million in 2021, then sank by 66.67% to $28.0 million in 2022, then plunged by 92.86% to $2.0 million in 2023, then surged by 1450.0% to $31.0 million in 2024, then fell by 9.68% to $28.0 million in 2025.
• Business Quant data shows ABBV's Short-term Investments at $28.0 million in Q4 2025, $42.0 million in Q3 2025, and $1.0 million in Q1 2025.